Item Type | Name |
Concept
|
Needs Assessment
|
Concept
|
Self-Assessment
|
Concept
|
Treatment Outcome
|
Concept
|
Clinical Trials, Phase III as Topic
|
Concept
|
Clinical Trials, Phase II as Topic
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
Concept
|
Clinical Protocols
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Risk Assessment
|
Concept
|
Clinical Decision-Making
|
Concept
|
Patient Reported Outcome Measures
|
Concept
|
Adaptive Clinical Trials as Topic
|
Concept
|
Clinical Deterioration
|
Concept
|
Symptom Assessment
|
Concept
|
Patient Outcome Assessment
|
Academic Article
|
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.
|
Academic Article
|
Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.
|
Academic Article
|
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.
|
Academic Article
|
Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis.
|
Academic Article
|
Design of Idiopathic Pulmonary Fibrosis Clinical Trials in the Era of Approved Therapies.
|
Academic Article
|
Racial Segregation and Respiratory Outcomes among Urban Black Residents with and at Risk of Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
|
Academic Article
|
Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction.
|
Academic Article
|
Comparison of Pirfenidone and Nintedanib: Post Hoc Analysis of the CleanUP-IPF Study.
|
Academic Article
|
Analysis of culture-dependent versus culture-independent techniques for identification of bacteria in clinically obtained bronchoalveolar lavage fluid.
|
Academic Article
|
The value of early diagnosis for effective management of chronic obstructive pulmonary disease.
|
Academic Article
|
A simplified score to quantify comorbidity in COPD.
|
Academic Article
|
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.
|
Academic Article
|
Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial.
|
Academic Article
|
Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
The Effect of Chronic Altitude Exposure on Chronic Obstructive Pulmonary Disease Outcomes in the SPIROMICS Cohort: An Observational Cohort Study.
|
Academic Article
|
Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.
|
Academic Article
|
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study.
|
Academic Article
|
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.
|
Academic Article
|
Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study.
|
Academic Article
|
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.
|
Academic Article
|
Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS).
|
Academic Article
|
Clinical and Genetic Associations of Objectively Identified Interstitial Changes in?Smokers.
|
Academic Article
|
Clinical significance of radiologic characterizations in COPD.
|
Academic Article
|
Screening for Chronic Obstructive Pulmonary Disease: Unmet Needs and Future Considerations.
|
Academic Article
|
Physiological and computed tomographic predictors of outcome from lung volume reduction surgery.
|
Academic Article
|
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.
|
Academic Article
|
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial).
|
Academic Article
|
Pitfalls in developing new compounds for idiopathic pulmonary fibrosis.
|
Academic Article
|
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort.
|
Academic Article
|
Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials.
|
Academic Article
|
Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial.
|
Academic Article
|
Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIR.
|
Academic Article
|
ECG-based risk factors for adverse cardiopulmonary events and treatment outcomes in COPD.
|
Academic Article
|
Interstitial lung disease, lung cancer, lung transplantation, pulmonary vascular disorders, and sleep-disordered breathing in AJRCCM in 2004.
|
Academic Article
|
Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study.
|
Academic Article
|
International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials.
|
Academic Article
|
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes.
|
Academic Article
|
A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography.
|
Academic Article
|
Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).
|
Academic Article
|
Any Decrease in Lung Function is Associated With Worse Clinical Outcomes: Post Hoc Analysis of the IMPACT Interventional Trial.
|
Academic Article
|
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency.
|
Academic Article
|
Impact of the COVID-19 Pandemic on Outcomes of CAPTURE: A Primary Care Chronic Obstructive Pulmonary Disease Screening Clinical Trial.
|
Academic Article
|
Treatment of Persistent Cough in Subjects with Idiopathic Pulmonary Fibrosis (IPF) with Gefapixant, a P2X3 Antagonist, in a Randomized, Placebo-Controlled Clinical Trial.
|
Academic Article
|
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial.
|
Academic Article
|
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement.
|
Academic Article
|
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
|
Academic Article
|
Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Assessment of patients with chronic obstructive pulmonary disease.
|
Academic Article
|
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
|
Academic Article
|
Integrating health status and survival data: the palliative effect of lung volume reduction surgery.
|
Academic Article
|
Outcomes for COPD pharmacological trials: from lung function to biomarkers.
|
Academic Article
|
Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis and Right Heart Dysfunction. A Prespecified Subgroup Analysis of a Double-Blind Randomized Clinical Trial (INSTAGE).
|
Academic Article
|
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial.
|
Academic Article
|
Acute exacerbation of chronic bronchitis: expanding short-course therapy.
|
Academic Article
|
Short-term and long-term outcomes after bilateral lung volume reduction surgery : prediction by quantitative CT.
|
Academic Article
|
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.
|
Academic Article
|
Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory Outcomes.
|
Academic Article
|
MMP mediated degradation of type IV collagen alpha 1 and alpha 3 chains reflects basement membrane remodeling in experimental and clinical fibrosis--validation of two novel biomarker assays.
|
Academic Article
|
Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS).
|
Academic Article
|
Protocol Summary of the COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) Validation in Primary Care Study.
|
Academic Article
|
Precision medicine in COPD: where are we and where do we need to go?
|
Academic Article
|
Clinical Approach to the Therapy of Asthma-COPD Overlap.
|
Academic Article
|
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
|
Academic Article
|
Relationship between pathologic characteristics of peripheral airways and outcome after lung volume reduction surgery in severe chronic obstructive pulmonary disease.
|
Academic Article
|
Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD).
|
Academic Article
|
Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment.
|
Academic Article
|
An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials.
|
Academic Article
|
Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
|
Academic Article
|
Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting ?2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial.
|
Academic Article
|
Chronic Respiratory Symptoms with Normal Spirometry. A Reliable Clinical Entity?
|
Academic Article
|
Establishing content-validity of a disease-specific health-related quality of life instrument for patients with chronic hypersensitivity pneumonitis.
|
Academic Article
|
Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.
|
Academic Article
|
Ratio of FEV1/Slow Vital Capacity of?< 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.
|
Academic Article
|
Baseline values and short serial change: a "road map" for a poor early outcome in idiopathic pulmonary fibrosis.
|
Academic Article
|
Changes in the lung microbiome following lung transplantation include the emergence of two distinct Pseudomonas species with distinct clinical associations.
|
Academic Article
|
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort.
|
Academic Article
|
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
|
Academic Article
|
Azithromycin for prevention of exacerbations of COPD.
|
Academic Article
|
Closing the Evidence Gap in Interstitial Lung Disease. The Promise of Real-World Data.
|
Academic Article
|
Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial.
|
Academic Article
|
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
|
Academic Article
|
The effect of exacerbation history on outcomes in the IMPACT trial.
|
Academic Article
|
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
|
Academic Article
|
Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts.
|
Academic Article
|
Association between Emphysema and Chronic Obstructive Pulmonary Disease Outcomes in the COPDGene and SPIROMICS Cohorts: A Post Hoc Analysis of Two Clinical Trials.
|
Academic Article
|
Optimizing the 6-min walk test as a measure of exercise capacity in COPD.
|
Academic Article
|
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial.
|
Academic Article
|
Patient-reported Outcomes for the Detection, Quantification, and Evaluation of Chronic Obstructive Pulmonary Disease Exacerbations.
|
Academic Article
|
Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients.
|
Academic Article
|
Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort.
|
Academic Article
|
Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS.
|
Academic Article
|
Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials.
|
Academic Article
|
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials.
|
Academic Article
|
The clinical impact of non-obstructive chronic bronchitis in current and former smokers.
|
Academic Article
|
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization.
|
Academic Article
|
Update in diffuse parenchymal lung diseases 2005.
|
Academic Article
|
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
|
Academic Article
|
Risk of Exacerbation and Pneumonia with Single-Inhaler Triple versus Dual Therapy in IMPACT.
|
Academic Article
|
Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease.
|
Academic Article
|
Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort.
|
Academic Article
|
An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research.
|
Academic Article
|
Confronting the Challenge of COPD: What Is New in the Approaches to Diagnosis, Treatment, and Patient Outcomes.
|
Academic Article
|
Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene.
|
Academic Article
|
Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis.
|
Academic Article
|
Effects of baseline symptom burden on treatment response in COPD.
|
Academic Article
|
The influence of social support on COPD outcomes mediated by depression.
|
Academic Article
|
Surgical therapy for chronic obstructive pulmonary disease.
|
Academic Article
|
Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS).
|
Academic Article
|
Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).
|
Academic Article
|
TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Community-acquired pneumonia.
|
Academic Article
|
The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions.
|
Academic Article
|
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort.
|
Academic Article
|
CT metrics of airway disease and emphysema in severe COPD.
|
Academic Article
|
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial.
|
Academic Article
|
Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk.
|
Academic Article
|
Prevalence and clinical correlates of bronchoreversibility in severe emphysema.
|
Academic Article
|
Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial.
|
Academic Article
|
Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
|
Academic Article
|
Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey.
|
Academic Article
|
Gender influences Health-Related Quality of Life in IPF.
|
Academic Article
|
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.
|
Academic Article
|
POINT: Can Screening for COPD Improve Outcomes? Yes.
|
Academic Article
|
Effect of Triple Therapy on Cardiovascular and Severe Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis of a Randomized, Double-Blind, Phase 3 Clinical Trial (ETHOS).
|
Academic Article
|
Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease.
|
Academic Article
|
Pulse Wave Velocity in Chronic Obstructive Pulmonary Disease and the Impact of Inhaled Therapy (SUMMIT): A Randomized Double-Blind Clinical Trial.
|
Academic Article
|
Weight gain after lung volume reduction surgery is not correlated with improvement in pulmonary mechanics.
|
Academic Article
|
Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease.
|
Academic Article
|
Clinical implications of macrolide therapy in chronic sinopulmonary diseases.
|
Academic Article
|
A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Integrating Clinical Probability into the Diagnostic Approach to Idiopathic Pulmonary Fibrosis: An International Working Group Perspective.
|
Academic Article
|
Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement.
|
Academic Article
|
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.
|
Academic Article
|
Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease.
|
Academic Article
|
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
|
Academic Article
|
Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study.
|
Academic Article
|
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.
|
Academic Article
|
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
|
Academic Article
|
A Phase IIb Randomized Clinical Study of an Anti-av?6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene.
|
Academic Article
|
Serum IgG Levels and Risk of COPD Hospitalization: A Pooled Meta-analysis.
|
Academic Article
|
Long-Acting ?-Agonist/Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease with Cardiovascular Disease or Risk: A Factorial Analysis of the SUMMIT Clinical Trial.
|
Academic Article
|
Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia.
|
Academic Article
|
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.
|
Academic Article
|
Surgical patient outcomes after the increased use of bilateral lung transplantation.
|
Academic Article
|
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.
|
Academic Article
|
The Effect of Inhaled Corticosteroid Withdrawal and Baseline Inhaled Treatment on Exacerbations in the IMPACT Study. A Randomized, Double-Blind, Multicenter Clinical Trial.
|
Academic Article
|
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab.
|
Academic Article
|
Composite endpoints in COPD: clinically important deterioration in the UPLIFT trial.
|
Academic Article
|
Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.
|
Academic Article
|
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved?Spirometry in SPIROMICS.
|
Academic Article
|
Effect of daily azithromycin therapy and adherence on readmission risk in COPD.
|
Academic Article
|
Longitudinal Outcomes in Pi*MZ Alpha-1 Antitrypsin Deficient Individuals with Tobacco Smoking History from the SPIROMICS Cohort.
|
Academic Article
|
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
|
Academic Article
|
Deep Learning Estimation of Small Airways Disease from Inspiratory Chest CT: Clinical Validation, Repeatability, and Associations with Adverse Clinical Outcomes in COPD.
|